分红方面，广康生化A股上市后累计派现4995.00万元。 融资方面，广康生化当日融资买入677.00万元。当前融资余额8791.47万元，占流通市值的8.37%，融资 余额超过近一年70%分位水平，处于较高位。 融券方面，广康生化9月23日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年90%分位水平，处于高位。 资料显示，广东广康生化科技股份有限公司位于广东省广州市天河区高普路97号A-B座6楼(601-603 房)，成立日期2003年10月17日，上市日期2023年6月27日，公司主营业务涉及专业从事农药原药、中间 体、制剂的研发、生产和销售的国家高新技术企业,是国内琥珀酸脱氢酶抑制剂(SDHI)、三氯甲基硫类 杀菌剂、联苯肼类杀螨剂、拟除虫菊酯类杀虫剂的主要供应商之一。主营业务收入构成为：原药 82.42%，制剂17.31%，农药中间体0.15%，其他(补充)0.12%。 截至6月30日，广康生化股东户数1.08万，较上期增加26.57%；人均流通股2555股，较上期减少 20.99%。2025年1月-6月，广康生化实现营 ...

Group 1 - The company held a performance briefing on September 19, 2025, to discuss its mid-year results with investors [1] - The event was attended by the company's chairman, general manager, and financial director, allowing for in-depth communication with investors [1] Group 2 - Despite challenges in the agricultural chemical industry, the company achieved revenue and profit growth in the first half of the year due to improved market conditions and strong demand for specific products [2] - The company is focusing on enhancing cooperation with core customers and increasing production capacity, particularly for its Klobucan and Sterilization products, which are expected to drive further performance growth [2] - The company addressed concerns regarding its declining stock price and shareholder sell-offs, attributing these fluctuations to macroeconomic factors and stating that recent sell-offs were normal financial behaviors by long-term investors [2]

Group 1: Company Performance - The company achieved revenue and profit growth in the first half of the year despite challenges in the agricultural chemical industry, such as overcapacity and price pressure [2] - The company's production and sales of key products, such as Keguan Dan and Mie Jun Dan, have increased significantly, with the production capacity being fully utilized [2] - The company is actively advancing the expansion plan for Mie Jun Dan to meet the growing customer demand, which is expected to enhance its market share and competitiveness globally [2] Group 2: Market and Investor Relations - The recent decline in stock price and shareholder sell-offs are attributed to macroeconomic factors, industry cycles, and market sentiment, which are beyond the company's control [3] - The company emphasizes its commitment to maintaining market value and has disclosed a stock price stabilization plan in its prospectus, which will be executed if certain conditions are met [3] - The company reassures investors of its stable operational activities and strategic planning, expressing confidence in long-term growth and performance [3]

证券代码：300804 证券简称：广康生化 公告编号：2025-047 2025 年中报业绩说明会的公告 广东广康生化科技股份有限公司 董事会 广东广康生化科技股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 为进一步加强与投资者的互动交流，广东广康生化科技股份有限公司（以下 简称"公司"）将参加由广东证监局、广东上市公司协会联合举办的"向新提质 价值领航——2025年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明 会"活动，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演APP, 参与本次互动交流，活动时间为2025年9月19日（周五）15:30-17:00。 届时公司董事长、总经理蔡丹群先生和公司董事会秘书、财务总监陈海霞女 士将在线就2025年半年度业绩、公司治理、发展战略、经营状况和可持续发展等 投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告！ 关于参加广东辖区上市公司投资者网上集体接 ...

Group 1 - Dashi Intelligent signed a contract worth 23.86 million yuan for the Xiaomi Wuhan Phase II smart project, providing a comprehensive smart space solution [1] - ST Tian Sheng's subsidiary passed the consistency evaluation for sodium bicarbonate injection, used for treating metabolic acidosis and certain drug poisonings [1] - Yongyue Technology's actual controller Chen Xiang was released on bail due to allegations of information disclosure violations, while the company's operations remain normal [2] Group 2 - Jushen Co. experienced a stock price fluctuation with a cumulative increase of over 20% over three trading days, while also planning to reduce repurchased shares [2][3] - Shanghai Airport reported a 6.9% year-on-year increase in passenger throughput at Pudong International Airport, totaling 7.9471 million passengers in August [3][4] - Jianlong Micro-Nano announced plans for shareholders to reduce up to 3% of company shares due to fund expiration and exit arrangements [5][6] Group 3 - Yunyong Technology's shareholders plan to reduce up to 2.99% of company shares due to personal funding needs [6] - Zitian Tui's stock entered a delisting arrangement period, expected to last 15 trading days [7] - Pruis's shareholders plan to reduce up to 3% of company shares for personal funding needs [9] Group 4 - Dayilong's shareholders plan to reduce up to 3% of company shares for personal financial arrangements [10] - Yihua New Materials' shareholders plan to reduce up to 1% of company shares for personal funding needs [12] - Huibo Yuntong's controlling shareholder's affiliates plan to acquire a controlling stake in Baode Computer [13] Group 5 - Wanda Information's shareholders plan to reduce up to 3% of company shares for operational needs [14] - Jiafa Education's shareholders plan to reduce up to 3% of company shares for personal funding needs [15] - Guangkang Biochemical's shareholders plan to reduce up to 1.8% of company shares for personal funding needs [16] Group 6 - Yingxin Development's shareholders plan to reduce up to 0.67% of company shares due to bankruptcy asset disposal [18] - Weiye Co.'s shareholders plan to reduce a total of up to 2% of company shares [19] - Kelin Electric plans to raise up to 1.5 billion yuan through a private placement to supplement working capital [20]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets released important announcements on September 14, providing insights for investors [3] Major Events - Yushen Co., Ltd. experienced abnormal stock fluctuations, with a cumulative price increase of over 20% in three consecutive trading days. The company plans to reduce its repurchased shares by up to 1% of its total share capital, consistent with its previously disclosed reduction plan [4][5] - Huibo Yuntong announced that its controlling shareholder, Shenhui Jinwu, intends to acquire 22.0875% of Baode Computing's shares, gaining control of the company. The total transaction price is approximately 1.444 billion yuan, with the acquisition expected to optimize Baode's equity structure and governance [5][6] - ST Zitian's stock will resume trading on September 15 and enter a delisting arrangement period of 15 trading days, with the last trading date expected to be October 13 [7] - Yongyue Technology's actual controller, Chen Xiang, has been released on bail due to an investigation related to the disclosure of important information. The company's operations remain normal [8] - ST Tiansheng's sodium bicarbonate injection has passed the consistency evaluation for generic drugs, indicating its clinical applicability for treating metabolic acidosis [9] Shareholding Changes - Jifa Education's shareholder, Deyuan Tai, plans to reduce its stake by up to 3%, equating to 11.9854 million shares [10] - Dayilong's shareholder intends to reduce its stake by up to 3%, amounting to 5.9708 million shares [11] - Pruis's shareholder, Guanyu Zhao Tai, plans to reduce its stake by up to 3%, totaling 2.3701 million shares [13] - Wanda Information's shareholder, Hexie Health, plans to reduce its stake by up to 3%, equating to 43.2189 million shares [14] - Jianlong Micro-Nano's shareholders plan to reduce their combined stake by up to 3%, totaling 3.0018 million shares [15] - Yunrong Technology's shareholder plans to reduce its stake by up to 2.99%, amounting to 1.8 million shares [16] - Guokang Biochemical's shareholders plan to reduce their stake by up to 1.7973%, totaling 1.33 million shares [17] - Yihua New Materials' shareholder plans to reduce its stake by up to 1%, equating to 1.655 million shares [18] - Yingxin Development's shareholder plans to reduce its stake by 0.67%, amounting to 3.9388 million shares [19] Performance Insights - Shanghai Airport reported an increase in passenger throughput for August, with Pudong International Airport reaching 7.9471 million passengers (up 6.9% year-on-year) and Hongqiao International Airport reaching 4.4515 million passengers (up 2.18% year-on-year) [20][21] Major Contracts - Dashi Intelligent signed a contract worth 23.869 million yuan for the Xiaomi Wuhan Phase II smart project, representing 0.75% of the company's audited revenue for 2024 [22]

Key Points - The article summarizes important announcements from various companies for investor reference [1] Group 1: Stock Performance and Trading - Jushen Co., Ltd. (炬申股份) experienced a stock price fluctuation with a cumulative increase of over 20% from September 10 to September 12, 2025, and is consistent with its previously disclosed share reduction plan [3] - ST Zitian (*ST紫天) will resume trading on September 15, 2025, and enter a delisting arrangement period lasting 15 trading days, with the last trading date expected to be October 13, 2025 [5] Group 2: Mergers and Acquisitions - Huibo Yuntong (慧博云通) announced that its controlling shareholder plans to acquire a total of 32.0875% of Baode Computing's shares for a total transaction price of 1.444 billion yuan, which will grant control over Baode Computing [4] Group 3: Shareholder Actions - Jifa Education (佳发教育) announced that its shareholder, De Yuan Tai, plans to reduce its stake by up to 3%, equating to 11.9854 million shares [9] - Da Yi Long (达意隆) disclosed that its shareholder, Shenzhen Lefeng Investment Management Co., Ltd., intends to reduce its stake by up to 3%, or 5.9708 million shares [10] - Multiple companies, including Pruis (普蕊斯), Wanda Information (万达信息), and Jianlong Micro-Nano (建龙微纳), reported plans for shareholders to reduce their stakes by up to 3% [11][13][14] Group 4: Operational Updates - Yongyue Technology (永悦科技) announced that its actual controller, Chen Xiang, has been released on bail pending trial due to an investigation related to information disclosure [6] - ST Tiansheng (ST天圣) received approval for its sodium bicarbonate injection to pass the consistency evaluation for generic drugs, which is used in clinical treatments [7] Group 5: Performance Metrics - Shanghai Airport (上海机场) reported that in August 2025, Pudong International Airport had a passenger throughput of 7.9471 million, a year-on-year increase of 6.9%, while Hongqiao International Airport had 4.4515 million, a 2.18% increase [20] Group 6: Contract Awards - Dashi Intelligent (达实智能) signed a contract worth 23.869 million yuan for the Xiaomi Wuhan Phase II intelligent project, which represents 0.75% of the company's audited revenue for 2024 [22]

每经头条（nbdtoutiao）——重大突破！中国这款新药，中美官方都认定有突破性疗效！世界肺癌大会 沸腾了 （记者 张喜威） 截至发稿，广康生化市值为30亿元。 每经AI快讯，广康生化（SZ 300804，收盘价：40.98元）9月14日晚间发布公告称，广东广康生化科技 股份有限公司的股东共青城华拓至盈贰号投资合伙企业（有限合伙）目前持有公司股份约88万股（占公 司总股本比例为1.1951%）；深圳市华拓至远叁号投资企业（有限合伙）目前持有公司股份约45万股 （占公司总股本比例为0.6022%）。根据《广东广康生化科技股份有限公司首次公开发行股票并在创业 板上市招股说明书》，相关股东因共同的基金管理人为深圳市华拓私募股权投资基金管理有限公司，合 并计算股份比例，合并计算后相关股东合计持有公司股份133万股（占公司总股本比例为1.7973%）。 现相关股东计划自本公告披露日起的3个交易日后的3个月内通过集中竞价、大宗交易方式合计减持公司 股份不超过133万股，即不超过公司总股本的1.7973%。 2024年1至12月份，广康生化的营业收入构成为：农药占比99.84%，其他业务占比0.16%。 ...

公司的股东共青城华拓至盈贰号投资合伙企业(有限合伙)目前持有公司股份88.44万股(占公司总股本比 例1.1951%)；深圳市华拓至远叁号投资企业(有限合伙)目前持有公司股份44.56万股(占公司总股本比例 0.6022%)。根据《广东广康生化科技股份有限公司首次公开发行股票并在创业板上市招股说明书》，上 述股东因共同的基金管理人(执行事务合伙人)为深圳市华拓私募股权投资基金管理有限公司，合并计算 股份比例，合并计算后上述股东合计持有公司股份133万股(占公司总股本比例1.7973%)。 格隆汇9月14日丨广康生化(300804.SZ)公布，股东深圳市华拓至远叁号投资企业(有限合伙)、共青城华 拓至盈贰号投资合伙企业(有限合伙)计划自公告披露日起的3个交易日后的3个月内通过集中竞价、大宗 交易方式合计减持公司股份不超过133万股，即不超过公司总股本的1.7973%。 ...

南财智讯9月14日电，广康生化公告，公司股东共青城华拓至盈贰号投资合伙企业（有限合伙）和深圳 市华拓至远叁号投资企业（有限合伙）计划自2025年9月18日起的3个月内，通过集中竞价和大宗交易方 式合计减持公司股份不超过133万股，即不超过公司总股本的1.7973%。减持原因为自身资金需求。截 至公告日，两位股东均严格遵守了在公司首次公开发行股票时作出的承诺。 ...